Co-Director of The Opioid Policy Research Collaborative at the Heller School for Social Policy and Management
Andrew Kolodny, M.D., is one of the nation's leading experts on the prescription opioid and heroin crisis. He is the Co-Director of The Opioid Policy Research Collaborative at the Heller School for Social Policy and Management. His primary area of focus is the prescription opioid and heroin crisis devastating families and communities across the country. He is also the executive director of Physicians for Responsible Opioid Prescribing, an organization with a mission to reduce morbidity and mortality caused by overprescribing of opioid analgesics.
Dr. Kolodny previously served as Chief Medical Officer for Phoenix House, a national non-profit addiction treatment agency and Chair of Psychiatry at Maimonides Medical Center in New York City. Dr. Kolodny has a long-standing interest in public health. He began his career working for the New York City Department of Health and Mental Hygiene in the Office of the Executive Deputy Commissioner. For New York City, he helped develop and implement multiple programs to improve the health of New Yorkers and save lives, including citywide buprenorphine programs, Naloxone overdose prevention programs and emergency room-based screening, brief intervention and referral to treatment (SBIRT) programs for drug and alcohol misuse.